Published in Ann Hematol on November 24, 2004
Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol (2012) 1.33
Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci U S A (2006) 1.08
Anemia of inflammation. Hematol Oncol Clin North Am (2014) 1.02
Anemia in inflammatory bowel disease: an under-estimated problem? Front Med (Lausanne) (2015) 0.81
[Anemia in patients with rheumatoid arthritis]. Z Rheumatol (2012) 0.77
Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency. Anemia (2010) 0.76
The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy (1994) 2.58
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med (1991) 2.40
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2000) 2.19
Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood (1989) 1.74
High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood (1997) 1.74
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am (2000) 1.69
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Ann Rheum Dis (2009) 1.59
Antibodies to hepatitis C virus. Lancet (1989) 1.47
Degradation of various amine compounds by mesophilic clostridia. Arch Microbiol (1986) 1.41
Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all-trans retinoic acid and haemopoietic growth factors. Br J Haematol (1995) 1.39
High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. Ann Oncol (1998) 1.38
Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med (2000) 1.36
The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford) (2006) 1.31
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol (1999) 1.25
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia (2012) 1.23
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J (2012) 1.22
Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand (1986) 1.17
Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment. Leukemia (2003) 1.16
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia. Ann Hematol (2004) 1.15
Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest (1987) 1.13
Lactic acidosis during metformin treatment in an elderly diabetic patient with impaired renal function. Acta Med Scand (1981) 1.11
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol (1990) 1.09
Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol (1990) 1.07
Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood (1987) 1.06
Lipid granulomatosis: Erdheim-Chester disease. Clin Nucl Med (1988) 1.05
Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest (1981) 1.05
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia (2006) 1.05
Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. Leuk Res (2001) 1.05
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol (2001) 1.04
Optical evaluation of red blood cell geometry using micropipette aspiration. Blood Cells (1992) 1.04
Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol (1998) 1.03
Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun (2005) 1.02
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology (1990) 1.02
Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood (1994) 1.02
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. Leukemia (2012) 1.02
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine. Haematologica (2001) 1.01
Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features. Leukemia (2005) 1.01
Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. J Immunol (1981) 1.00
dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer (1995) 1.00
Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia (2004) 0.99
Manual vacuum aspiration, a safe and effective alternative in early pregnancy termination. Acta Obstet Gynecol Scand (2001) 0.99
Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med (1991) 0.99
Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Ann Hematol (1995) 0.99
CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens (1998) 0.98
Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma (2001) 0.98
A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis (2008) 0.98
Genomic organization and regulation of the human interleukin-18 gene. Scand J Immunol (2000) 0.98
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia (2004) 0.97
Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood (1990) 0.97
Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Improved sensitivity for detecting epidermal cancer cells. Arch Dermatol (1984) 0.97
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia (2002) 0.96
Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung (1986) 0.96
Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. J Viral Hepat (2007) 0.96
Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood (1984) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
[HIV testing after needlestick injury: must the index patient be informed?]. Dtsch Med Wochenschr (2008) 0.96
Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut (1998) 0.95
Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann Oncol (1993) 0.95
Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Ann Hematol (1995) 0.95
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Ann Hematol (2003) 0.95
Malignant hemangioendothelioma of the pericardium. A case report. Scand J Respir Dis (1970) 0.94
Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae? Lancet (1988) 0.94
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94
Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells. Stem Cells (2001) 0.94
The impact of the 2009 influenza A(H1N1) pandemic on attitudes of healthcare workers toward seasonal influenza vaccination 2010/11. Euro Surveill (2011) 0.94
Infection control practices in facilities for highly infectious diseases across Europe. J Hosp Infect (2012) 0.93
[Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units]. Z Gastroenterol (2008) 0.93
Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med (1997) 0.93
The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia. Leukemia (2009) 0.93
Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Br J Haematol (1992) 0.93
Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial. Ann Hematol (2004) 0.93
Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma. Ann Oncol (2002) 0.93
Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML. Br J Haematol (1998) 0.93
[Influenza: acceptance of vaccination by healthcare personnel. Evaluation of the influenza season 2006/2007]. Dtsch Med Wochenschr (2007) 0.92
Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. Am J Emerg Med (1984) 0.92
Meningeosis leukaemica in adult acute lymphoblastic leukaemia. J Neurooncol (1998) 0.92
Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis (2005) 0.91
Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia. J Clin Oncol (1988) 0.91
Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture. J Lab Clin Med (1993) 0.90
Risk/MRD adapted GMALL trials in adult ALL. Ann Hematol (2004) 0.90
Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration. Transplantation (1991) 0.90
The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol (1997) 0.90
[Influenza pandemic: Would healthcare workers come to work? An analysis of the ability and willingness to report to duty]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.90
Ongoing outbreak of tuberculosis in a low-incidence community: a molecular-epidemiological evaluation. Int J Tuberc Lung Dis (2004) 0.90
Using a topical anaesthetic cream to reduce pain during sharp debridement of chronic leg ulcers. J Wound Care (2001) 0.90
Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.90
The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group. Leukemia (1992) 0.89
Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. Hematol J (2001) 0.89
Interleukin-18 stimulates HIV-1 replication in a T-cell line. Eur Cytokine Netw (2000) 0.88